Table 2.
Treatment of invasive aspergillosis in non-neutropenic ICU patients [48]
| Setting | First choice | Alternatives |
|---|---|---|
| Primary therapy | Voriconazole (6 mg/kg every 12 hours intravenously on day 1, then 4 mg/kg every 12 hours intravenously) | Liposomial amphotericin B (3–5 mg/kg/day intravenously) or Echinocandins (usual dosage) |
| Salvage therapy | Combination of voriconazole plus amphotericin B/echinocandins | |